Mindfulness-Based Cognitive Therapy Intervention to Treat Depression in Individuals With a Traumatic Brain Injury

This study is currently recruiting participants.
Verified June 2011 by Lakehead University
Sponsor:
Collaborator:
Ontario Neurotrauma Foundation
Information provided by:
Lakehead University
ClinicalTrials.gov Identifier:
NCT00745940
First received: September 2, 2008
Last updated: June 24, 2011
Last verified: June 2011
  Purpose

The purpose of this study is to determine whether mindfulness-based cognitive therapy is effective in reducing depression symptoms in individuals who have experienced a traumatic brain injury.

The investigators hypothesize that participants who are given the ten-week intervention will have fewer depression symptoms than the participants in the control group, and this improvement will be maintained at the three-month follow-up assessment.


Condition Intervention
Depression
Traumatic Brain Injury
Behavioral: Mindfulness-Based Cognitive Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Multi-site, Randomized, Controlled Trial of a Mindfulness-based Cognitive Therapy Intervention for Treating Depression in a Traumatic Brain Injury Population.

Resource links provided by NLM:


Further study details as provided by Lakehead University:

Primary Outcome Measures:
  • Evidence of decreased depression symptoms as indicated by scores from a variety of scales (BDI-II, PHQ-9, HADS and SCL-90-R). [ Time Frame: End of treatment, 3-month follow-up ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Evidence of improvements in pain intensity (VAS), general/mental health (SF-36), functioning (MPAI-4, MIRECC-GAF), attention/concentration (Digit Section of WAIS), satisfaction with life (SWLS), and other psychological symptoms (SCLR-90-R). [ Time Frame: End of treatment, 3-month follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: November 2009
Estimated Study Completion Date: February 2012
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1. MBCT Intervention Behavioral: Mindfulness-Based Cognitive Therapy
Subjects will participate in a 10-week Mindfulness-Based Cognitive Therapy Program led by two trained facilitators. Weekly one-and-a-half hour group sessions will guide subjects through exercises such as meditation, awareness, and breathing techniques aimed at developing skills to help with tension, stress, anxiety and depression. Subjects will be encouraged to practice skills at home and in daily life.
Other Name: MBCT
No Intervention: 2. Control

Detailed Description:

Major depression is a significant chronic problem for people with traumatic brain injury (TBI), and its treatment is difficult. A promising approach to treat depression is mindfulness-based cognitive therapy (MBCT), a relatively new therapeutic approach rooted in mindfulness-based stress-reduction (MBSR) and cognitive behavioural therapy (CBT). This multi-site, randomized, controlled trial of a MBCT intervention will examine the value of this intervention in improving quality of life and decreasing depression in people with TBI. MBCT may represent a time-limited, cost-effective group intervention through which clinicians would have an opportunity to address some of the most debilitating aspects of TBI.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • TBI suffered more than one year ago but less than five
  • Evidence of depression post-TBI (BDI-II score of 16 or greater)
  • Ability to speak and read English
  • Age 18 or more

Exclusion Criteria:

  • Evidence of post-traumatic amnesia (GOAT)
  • Inability to benefit from the intervention based a consensus process amongst study clinical psychologist and physicians, and from scores on memory and auditory attention (CVLT, Digit Span subsection of WAIS); verbal fluency and executive functioning (COWAT); verbal abstract reasoning (Similarities subsection of WAIS); and executive functioning (Trail Making Test, Stroop Test).
  • Evidence of unusual psychological processes such as psychosis, suicidal ideation, substance abuse, or major concurrent mental illness (BDI-II and SCL-90-R will supplement the decision-making process of study clinicians).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00745940

Contacts
Contact: Michel Bédard, PhD 807-343-8630 mbedard@lakeheadu.ca

Locations
Canada, Ontario
Ottawa Hospital Rehabilitation Centre Recruiting
Ottawa, Ontario, Canada, K1H 8M2
Principal Investigator: Shawn Marshall, MD MSc FRCPC            
St. Joseph's Care Group Recruiting
Thunder Bay, Ontario, Canada, P7B 5G7
Principal Investigator: Michel Bédard, PhD            
Toronto Rehabilitation Institute Recruiting
Toronto, Ontario, Canada, M5G 2A2
Principal Investigator: Nora Cullen, MD MSc FRCPC            
Sponsors and Collaborators
Lakehead University
Ontario Neurotrauma Foundation
Investigators
Principal Investigator: Michel Bédard, PhD Lakehead University
  More Information

No publications provided

Responsible Party: Michel Bédard, Lakehead University
ClinicalTrials.gov Identifier: NCT00745940     History of Changes
Other Study ID Numbers: ABI-MIND2-476
Study First Received: September 2, 2008
Last Updated: June 24, 2011
Health Authority: Canada: Ethics Review Committee

Keywords provided by Lakehead University:
Mindfulness-Based Cognitive Therapy
MBCT
Depression
Traumatic Brain Injury
TBI

Additional relevant MeSH terms:
Depression
Depressive Disorder
Brain Injuries
Behavioral Symptoms
Mood Disorders
Mental Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries

ClinicalTrials.gov processed this record on May 16, 2013